Cysteine protease inhibitor MK-0822, Purity ≥98%

Synonym: 603139-19-1; Cysteine protease inhibitor; MK0822

MDL: MFCD11042419
CAS Number: 603139-19-1
Compound CID: 10152654

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

MK-0822, soluble in DMSO and insoluble in ethanol and water, obstructs cysteine proteases, enzymes implicated in numerous diseases due to their role in protein degradation. It targets Cathepsin K (human) and Cathepsin K (rabbit).

Molecular Weight

525.6

Molecular Formula

C₂₅H₂₇F₄N₃O₃S

Targets

Cathepsin K (human): 0.2 nM; Cathepsin K (rabbit): 1 nM

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 96 mg/mL (182.66 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

MK-0822 inhibits effects on cysteine proteases, enzymes linked to bone resorption conditions like osteoporosis.